FORM 2 - Corporate Substantial Shareholder Notice
 
Form Serial Number: CS20260826E00379 
1. Date of relevant event: 24/08/2026
(dd/mm/yyyy)
2. Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02142
4. Name of listed corporation: 和鉑醫藥控股有限公司 - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 900,976,522
7. Name of substantial shareholder: 北京君祺嘉睿企业管理有限公司 
8. Registered office: 北京市海淀区科学院南路2号院1号楼16层1614
9. Principal place of business in Hong Kong: N/A 
15. Exchange on which listed:
16. Name of listed parent and exchange on which parent is listed:  
17. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Nature of consideration
Long position
1704Miscellaneous
Notice filed because you ceased to have a notifiable interest in the shares of the listed corporation (you must briefly describe the relevant event in the Supplementary Information box)
2201Interest of corporation controlled by you
8,432,000 HKD 15.7861
Short position 
 
 
 		            
18. Total shares immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position52,235,0005.85
19. Total shares immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position43,803,0004.86
20. Capacity in which interests disclosed in Box 19 are held:
Capacity codeNumber of shares
2201Interest of corporation controlled by you
Long position43,803,000

21. Further information in respect of derivative interests:
Derivatives codeNumber of shares
  
22. Further information in relation to interests of corporations controlled by substantial shareholder:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
LC Healthcare Fund I, L.P.PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman IslandsLC Healthcare Fund I GP, L.P. (as general partner)100.00Y
Long position43,803,000
LC Healthcare Fund I GP, L.P.PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman IslandsLC Fund GP Limited (as general partner)100.00N
Long position43,803,000
LC Fund GP LimitedPO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman IslandsUnion Season Holdings Limited (as sole shareholder)100.00N
Long position43,803,000
Union Season Holdings LimitedOffice 6113, The Center, 99 Quees's Road Central, Central, Hong Kong君联资本管理股份有限公司 ( as sole shareholder)100.00N
Long position43,803,000
君联资本管理股份有限公司北京市海淀区科学院南路2号院1号楼16层1604北京君诚合众投资管理合伙企业（有限合伙）80.00N
Long position43,803,000
北京君诚合众投资管理合伙企业（有限合伙）北京市海淀区科学院南路2号院1号楼16层1609北京君祺嘉睿企业管理有限公司 (as general partner)49.88N
Long position43,803,000

23. Further information in relation to interests held by substantial shareholder jointly with another person:
Name of joint shareholderAddressNumber of shares
 
24. Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust:
Names of trustAddressStatus codeNumber of shares
  
25. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a substantial shareholder is interested under sections 317 and 318
26. Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act:
NamesAddressRelationship CodePercentage (%)
  
 
27. Supplementary information: 自本有关事件发生之日，申报人不再拥有《证券及期货条例》第 XV 部下的须具报权益。
28. Log/Serial Number of the previous form:
29. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 2: 26/08/2026
(dd/mm/yyyy)